NCT00365417
Therapy With Bevacizumab (BEV), Doxorubicin, and Cyclophosphamide Followed by BEV, Docetaxel, and Capecitabine Before Surgery Followed by BEV Alone After Surgery for Women With Locally Advanced Breast Cancer
Phase: Phase 2
Role: Collaborator
Start: Aug 31, 2006
Completion: Nov 30, 2009